B-hCD16A mice_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

Please input keywords

Order

*Country

한국

미국

일본

중국

영국

호주

프랑스

독일

이탈리아

싱가포르

인도

러시아

캐나다

스위스

기타 국가

*Province

*City

*Name

*Telephone

*Company

*Position

*Email

*Verification code

*Verification Code

Home

동물/세포 모델

동물/세포모델

Humanized Mouse Models

Humanizad Mouse Models

Text

B-hCD16A mice

Strain Name	C57BL/6-Fcgr4^{tm2(FCGR3A)Bcgen}/Bcgen	Common Name	B-hCD16A mice
Background	C57BL/6N	Catalog number	111173
Related Genes	FCGR3A (Fc fragment of IgG receptor IIIa), CD16A
NCBI Gene ID	246256

mRNA expression analysis

from clipboard

Strain specific analysis of CD16A gene expression in wild-type mice and homozygous B-hCD16A mice by RT-PCR. Mouse Fcgr4 mRNA was exclusively detectable in wild-type mice and human FCGR3A mRNA was exclusively detectable in homozygous B-hCD16A mice (H/H).

Protein expression analysis in NK cells

from clipboard

Strain specific CD16A expression analysis in wild-type C57BL/6 mice and homozygous B-hCD16A mice by flow cytometry.
Splenocytes were collected from wild-type C57BL/6 mice(+/+) and homozygous B-hCD16A mice (H/H). Human CD16A was exclusively detectable in the NK cells of homozygous B-hCD16A mice.

Protein expression analysis in macrophages

Strain specific CD16A expression analysis in wild-type C57BL/6 mice and homozygous B-hCD16A mice by flow cytometry. Peritoneal exudative macrophages(PEMs) were collected from wild-type C57BL/6 mice(+/+) and homozygous B-hCD16A mice(H/H). Mouse CD16A was exclusively detectable in wild-type C57BL/6 mice. Human CD16A was exclusively detectable in homozygous B-hCD16A mice.

Protein expression analysis in multiple lymphocyte subtypes

NK cells

Strain specific CD16A expression analysis in wild-type C57BL/6 mice and homozygous B-hCD16A mice by flow cytometry.
Different tissues were collected from wild-type C57BL/6 mice(+/+) and homozygous B-hCD16A mice (H/H). Human CD16A was exclusively detectable in the NK cells of homozygous B-hCD16A mice.

Granulocytes

Strain specific CD16A expression analysis in wild-type C57BL/6 mice and homozygous B-hCD16A mice by flow cytometry.
Different tissues were collected from wild-type C57BL/6 mice(+/+) and homozygous B-hCD16A mice (H/H). Mouse CD16A was exclusively detective in granulocytes of wild-type mice. Human CD16A was not detectable in granulocytes of wild-type C57BL/6 mice or homozygous B-hCD16A mice.

Macrophages

Strain specific CD16A expression analysis in wild-type C57BL/6 mice and homozygous B-hCD16A mice by flow cytometry. Different tissues were collected from wild-type C57BL/6 mice(+/+) and homozygous B-hCD16A mice (H/H). Mouse CD16A was exclusively detective in macrophages of wild-type mice. Human CD16A was exclusively detectable in macrophages of homozygous B-hCD16A mice .

Summary

from clipboard

Protein expression analysis in NK cells

Strain specific CD16A expression level analysis in NK cells of homozygous B-hCD16A mice and human PBMCs by flow cytometry.

Analysis of leukocytes subpopulation in B-hCD16A mice

Analysis of spleen leukocyte subpopulations by FACS. Splenocytes were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old). Flow cytometry analysis of the splenocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for the CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.

Analysis of spleen T cell subpopulations in B-hCD16A mice

Analysis of spleen T cell subpopulations by FACS. Splenocytes were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old). Flow cytometry analysis of the splenocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for TCRβ+T cell population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.

Analysis of leukocytes subpopulation in B-hCD16A mice

Analysis of LNs leukocyte subpopulations by FACS. LNs were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old). Flow cytometry analysis of the LNs was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for the CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.

Analysis of LNs T cell subpopulations in B-hCD16A mice

Analysis of LNs T cell subpopulations by FACS. LNs were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old). Flow cytometry analysis of the LNs was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for TCRβ+T cell population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.

Analysis of leukocytes subpopulation in B-hCD16A mice

Analysis of blood leukocyte subpopulations by FACS. Blood were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old). Flow cytometry analysis of the blood was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for the CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.

Analysis of blood T cell subpopulations in B-hCD16A mice

Analysis of blood T cell subpopulations by FACS. Blood were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old). Flow cytometry analysis of the blood was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for TCRβ+T cell population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.

Tumor growth curve & Body weight changes

Subcutaneous homograft tumor growth of B-hCLDN18.2 MC38 cells, B-hBCMA MC38 cells and B-hB7-H3 MC38 cells in B-hCD16A mice.

B-hCLDN18.2 MC38 cells, B-hBCMA MC38 cells and B-hB7-H3 MC38 cells (5x10⁵) and wild-type MC38 cells (5x10⁵) were subcutaneously implanted into B-hCD16A mice (female, 8-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean± SEM). Volume was expressed in mm³ using the formula: V=0.5 X long diameter X short diameter². As shown in panel A, B-hCLDN18.2 MC38 cells, B-hBCMA MC38 cells and B-hB7-H3 MC38 cells were able to establish tumors in B-hCD16A mice and can be used for efficacy studies.

Tumor growth curve & Body weight changes

from clipboard

Subcutaneous homograft tumor growth of B-hEPCAM MC38 cells, B-hROR1 MC38 cells and B-hLILRB4 MC38 in B-hCD16A mice. B-hEPCAM MC38 cells, B-hROR1 MC38 cells and B-hLILRB4 MC38 (5x10⁵) and wild-type MC38 cells (5x10⁵) were subcutaneously implanted into B-hCD16A mice (female, 8-week-old, n=8). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean± SEM). Volume was expressed in mm³ using the formula: V=0.5 X long diameter X short diameter². As shown in panel A, B-hEPCAM MC38 cells, B-hROR1 MC38 cells and B-hLILRB4 MC38 were able to establish tumors in B-hCD16A mice and can be used for efficacy studies.

Tumor growth curve & Body weight changes

from clipboard

Subcutaneous homograft tumor growth of B-hCD19 MC38 cells and B-hTPBG MC38 in B-hCD16A mice. B-hCD19 MC38 cells, B-hTPBG MC38 (5x10⁵) and wild-type MC38 cells (5x10⁵) were subcutaneously implanted into B-hCD16A mice (female, 8-week-old, n=8). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean± SEM). Volume was expressed in mm³ using the formula: V=0.5 X long diameter X short diameter². As shown in panel A, B-hCD19 MC38 cells and B-hTPBG MC38 were able to establish tumors in B-hCD16A mice and can be used for efficacy studies.

Tumor growth curve & Body weight changes

from clipboard

Subcutaneous homograft tumor growth of B-hCLDN6 MC38 cells in B-hCD16A mice. B-hCLDN6 MC38 (5x10⁵) and wild-type MC38 cells (5x10⁵) were subcutaneously implanted into B-hCD16A mice (female, 8-week-old, n=8). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean± SEM). Volume was expressed in mm³ using the formula: V=0.5 X long diameter X short diameter². As shown in panel A, B-hCLDN6 MC38 cells was able to establish tumors in B-hCD16A mice and can be used for efficacy studies.

Antitumor activity of anti-human CD16A-based Ab in B-hCD16A mice

from clipboard

Antitumor activity of anti-human CD16A-based Ab in B-hCD16A mice. (A) Anti-human CD16A-based Ab inhibited MC38 tumor growth in B-hCD16A mice. Murine colon cancer MC38 cells were subcutaneously implanted into homozygous B-hCD16A mice (female,13 week-old, n=7). Mice were grouped when tumor volume reached approximately 70 mm³, at which time they were treated with anti-human CD16A-based Ab with doses and schedules indicated in panel B. (B) Body weight changes during treatment. As shown in panel A, anti-human CD16A-based Ab was efficacious in controlling tumor growth in B-hCD16A mice, demonstrating that the B-hCD16A mice provide a powerful preclinical model for in vivo evaluation of anti-human CD16A-based Ab. Values are expressed as mean ± SEM.